Filing Details

Accession Number:
0001593968-23-000108
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-09 17:27:21
Reporting Period:
2023-01-09
Accepted Time:
2023-01-09 17:27:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX Pharmaceutical Preparations (2834) 270605902
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1777631 K. Stephen Brannan C/O Karuna Therapeutics, Inc.
99 High Street, 26Th Floor
Boston MA 02110
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-09 1,527 $5.45 16,527 No 4 M Direct
Common Stock Disposition 2023-01-09 1,527 $197.52 15,000 No 4 S Direct
Common Stock Acquisiton 2023-01-09 3,473 $7.27 18,473 No 4 M Direct
Common Stock Disposition 2023-01-09 3,473 $197.52 15,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2023-01-09 1,527 $0.00 1,527 $5.45
Common Stock Option (right to buy) Disposition 2023-01-09 3,473 $0.00 3,473 $7.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,677 2027-06-01 No 4 M Direct
0 2028-08-08 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 8, 2022.
  2. This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of March 1, 2017, with additional vesting as to 12.5% of the shares underlying the option award at the end of each six month period thereafter.
  3. This option vested as to 12.5% of the shares underlying the option award on each six month anniversary following the vesting commencement date of August 8, 2018.